Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023321785> ?p ?o ?g. }
- W2023321785 endingPage "1604" @default.
- W2023321785 startingPage "1591" @default.
- W2023321785 abstract "Summary Luminal 5-HT time-dependently modulates visceral nociception through vagal 5-HT3 receptor-mediated anandamide/CB1 signaling pathway. Specific targeting of this pathway attenuates 5-HT-induced visceral hyperalgesia. Serotonin (5-HT) plays pivotal roles in the pathogenesis of postinfectious irritable bowel syndrome (PI-IBS), and luminal 5-HT time-dependently modulates visceral nociception. We found that duodenal biopsies from PI-IBS patients exhibited increased 5-HT and decreased anandamide levels and that decreased anandamide was associated with abdominal pain severity, indicating a link between 5-HT and endocannabinoid signaling pathways in PI-IBS. To understand this, we investigated the role of endocannabinoids in 5-HT modulation of visceral nociception in a rat model. Acute intraduodenally applied 5-HT attenuated the visceromotor response (VMR) to colorectal distention, and this was reversed by the cannabinoid receptor 1 (CB1) antagonist AM251. Duodenal anandamide (but not 2-arachidonoylglycerol) content was greatly increased after luminal 5-HT treatment. This effect was abrogated by the 5-HT 3 receptor (5-HT3R) antagonist granisetron, which was luminally delivered to preferentially target vagal terminals. Chemical denervation of vagal afferents blocked 5-HT-evoked antinociception and anandamide release. Chronic luminal 5-HT exposure for 5 days increased baseline VMR and VMR post-5-HT (days 4 and 5). Duodenal levels of anandamide and N-acyl-phosphatidylethanolamine-specific phospholipase D (NAPE-PLD, the anandamide-synthesizing enzyme) protein gradually declined from day 1 to 5. The time-dependent effects of 5-HT were abolished by daily granisetron pretreatment. Daily pretreatment with CB1 agonists or anandamide from day 3 attenuated 5-HT-induced hyperalgesia. These data suggest that vagal 5-HT3R-mediated duodenal anandamide release contributes to acute luminal 5-HT-induced antinociception via CB1 signaling, whereas decreased anandamide is associated with hyperalgesia upon chronic 5-HT treatment. Further understanding of peripheral vagal anandamide signaling may provide insights into the mechanisms underlying 5-HT-related IBS." @default.
- W2023321785 created "2016-06-24" @default.
- W2023321785 creator A5005496208 @default.
- W2023321785 creator A5005966689 @default.
- W2023321785 creator A5009173399 @default.
- W2023321785 creator A5024771395 @default.
- W2023321785 creator A5028953988 @default.
- W2023321785 creator A5058642590 @default.
- W2023321785 creator A5067061269 @default.
- W2023321785 creator A5067882551 @default.
- W2023321785 creator A5082857859 @default.
- W2023321785 date "2014-08-01" @default.
- W2023321785 modified "2023-10-17" @default.
- W2023321785 title "Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats" @default.
- W2023321785 cites W1482716043 @default.
- W2023321785 cites W1488329806 @default.
- W2023321785 cites W1588171067 @default.
- W2023321785 cites W1967307807 @default.
- W2023321785 cites W1981710900 @default.
- W2023321785 cites W1982142182 @default.
- W2023321785 cites W1983350548 @default.
- W2023321785 cites W1986788905 @default.
- W2023321785 cites W1989263093 @default.
- W2023321785 cites W1991319303 @default.
- W2023321785 cites W1997302824 @default.
- W2023321785 cites W2000129974 @default.
- W2023321785 cites W2004478827 @default.
- W2023321785 cites W2008541201 @default.
- W2023321785 cites W2008749179 @default.
- W2023321785 cites W2010857508 @default.
- W2023321785 cites W2028890830 @default.
- W2023321785 cites W2029775732 @default.
- W2023321785 cites W2034090778 @default.
- W2023321785 cites W2034339356 @default.
- W2023321785 cites W2052749982 @default.
- W2023321785 cites W2056225586 @default.
- W2023321785 cites W2058976148 @default.
- W2023321785 cites W2060606686 @default.
- W2023321785 cites W2061912427 @default.
- W2023321785 cites W2062922607 @default.
- W2023321785 cites W2068832387 @default.
- W2023321785 cites W2072553133 @default.
- W2023321785 cites W2078830320 @default.
- W2023321785 cites W2079345841 @default.
- W2023321785 cites W2079422629 @default.
- W2023321785 cites W2089056164 @default.
- W2023321785 cites W2096256974 @default.
- W2023321785 cites W2103516277 @default.
- W2023321785 cites W2107237727 @default.
- W2023321785 cites W2107277218 @default.
- W2023321785 cites W2115754584 @default.
- W2023321785 cites W2120884990 @default.
- W2023321785 cites W2126547777 @default.
- W2023321785 cites W2127837438 @default.
- W2023321785 cites W2134073124 @default.
- W2023321785 cites W2137510197 @default.
- W2023321785 cites W2143108753 @default.
- W2023321785 cites W2149363030 @default.
- W2023321785 cites W2155432259 @default.
- W2023321785 cites W2155907554 @default.
- W2023321785 cites W2156291426 @default.
- W2023321785 cites W2163069612 @default.
- W2023321785 cites W2165565545 @default.
- W2023321785 cites W2170556110 @default.
- W2023321785 cites W2171125004 @default.
- W2023321785 cites W2406276809 @default.
- W2023321785 cites W2945079589 @default.
- W2023321785 doi "https://doi.org/10.1016/j.pain.2014.05.005" @default.
- W2023321785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24813296" @default.
- W2023321785 hasPublicationYear "2014" @default.
- W2023321785 type Work @default.
- W2023321785 sameAs 2023321785 @default.
- W2023321785 citedByCount "34" @default.
- W2023321785 countsByYear W20233217852014 @default.
- W2023321785 countsByYear W20233217852015 @default.
- W2023321785 countsByYear W20233217852016 @default.
- W2023321785 countsByYear W20233217852017 @default.
- W2023321785 countsByYear W20233217852018 @default.
- W2023321785 countsByYear W20233217852019 @default.
- W2023321785 countsByYear W20233217852020 @default.
- W2023321785 countsByYear W20233217852021 @default.
- W2023321785 countsByYear W20233217852022 @default.
- W2023321785 countsByYear W20233217852023 @default.
- W2023321785 crossrefType "journal-article" @default.
- W2023321785 hasAuthorship W2023321785A5005496208 @default.
- W2023321785 hasAuthorship W2023321785A5005966689 @default.
- W2023321785 hasAuthorship W2023321785A5009173399 @default.
- W2023321785 hasAuthorship W2023321785A5024771395 @default.
- W2023321785 hasAuthorship W2023321785A5028953988 @default.
- W2023321785 hasAuthorship W2023321785A5058642590 @default.
- W2023321785 hasAuthorship W2023321785A5067061269 @default.
- W2023321785 hasAuthorship W2023321785A5067882551 @default.
- W2023321785 hasAuthorship W2023321785A5082857859 @default.
- W2023321785 hasConcept C126322002 @default.
- W2023321785 hasConcept C134018914 @default.
- W2023321785 hasConcept C148001335 @default.
- W2023321785 hasConcept C15490471 @default.
- W2023321785 hasConcept C170493617 @default.